News search

    E.g., 19/12/2025
    E.g., 19/12/2025
    Dr. Valentín Fuster, Dr. Xavier Rosselló y Dr. Borja Ibáñez.
    Research
    9 Nov 2025
    NEJM: Major international study confirms that beta-blockers are no longer needed in post-infarction patients with normal heart function

    The study, published in The New England Journal of Medicine, shows that beta-blockers do not reduce mortality, recurrent infarction, or heart failure in post-infarction patients with normal cardiac function
    CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
    Research
    30 Aug 2025
    NEJM & The Lancet: CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

    REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the heart intact.
    Research
    31 Mar 2025
    NEJM: A drug used to treat diabetes improves the prognosis of patients undergoing cardiac valve intervention

    The DapaTAVI study, conducted in 39 Spanish hospitals and coordinated by the CNIC, marks a breakthrough in cardiovascular research and could transform the treatment of these patients
    Dr. Fuster
    About the CNIC
    27 Oct 2023
    Mount Sinai Hospital changes its name to the “Mount Sinai Fuster Heart Hospital” in honour of Dr Fuster
    Dr. García Pavía
    Research
    21 May 2023
    NEJM: A Spanish team presents the first pharmacological treatment able to improve cardiac function in stiff-heart syndrome

    The team led by Dr. Pablo García-Pavía, based at the CNIC and Hospital Puerta de Hierro, has published the first study of a drug able to remove amyloid deposits from the heart

    Valentín Fuster
    Research
    26 Aug 2022
    NEJM: The polypill reduces cardiovascular mortality by 33% in patients treated after myocardial infarction

    The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM

    First biomarker in blood that distinguishes myocarditis from an acute myocardial infarction
    Research
    27 May 2021
    NEJM: The first blood biomarker to distinguish between myocarditis and acute myocardial infarction

    The diagnosis of acute myocarditis is challenging, and the availability of a sensitive and specific early marker of acute myocardial inflammation could have a major impact on its clinical diagnosis